---
figid: PMC3308137__nihms358197f2
figlink: /pmc/articles/PMC3308137/figure/F2/
number: F2
caption: miRNAs that promote or inhibit tumorigenesis provide diverse functions within
  oncogenic and tumor suppressor signaling pathways. (A) miR-34 family members and
  the miR-17-92 cluster function as signal mediators for the p53 and Myc pathways,
  respectively. (B) miR-16 negatively regulates multiple components of mitogenic pathways
  and thereby provides an inhibitory signal modulation function. (C) miR-146a is activated
  by NF-κB signaling and negatively feeds back on the pathway by repressing upstream
  activators of NF-κB. In this capacity, miR-146a restrains excessive NF-κB activity
  which can lead to tumorigenesis. (D) Let-7, miR-21, and the miR-143/145 cluster
  participate in positive feedback loops which function to stably enforce cellular
  transformation programs upon activation of oncogenes such as NF-κB, Kras, and Myc.
  (E) miR-26 can repress both pro-tumorigenic targets (cyclins D2 and E2) and anti-tumorigenic
  targets (PTEN). These opposing activities endow miR-26 with context-dependent positive
  or negative effects on tumorigenesis.
pmcid: PMC3308137
papertitle: MicroRNAs in stress signaling and human disease.
reftext: Joshua T. Mendell, et al. Cell. ;148(6):1172-1187.
pmc_ranked_result_index: '47874'
pathway_score: 0.9172199
filename: nihms358197f2.jpg
figtitle: miRNAs that promote or inhibit tumorigenesis provide diverse functions within
  oncogenic and tumor suppressor signaling pathways
year: ''
organisms: Homo sapiens
ndex: 6ca0fa55-de8f-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3308137__nihms358197f2.html
  '@type': Dataset
  description: miRNAs that promote or inhibit tumorigenesis provide diverse functions
    within oncogenic and tumor suppressor signaling pathways. (A) miR-34 family members
    and the miR-17-92 cluster function as signal mediators for the p53 and Myc pathways,
    respectively. (B) miR-16 negatively regulates multiple components of mitogenic
    pathways and thereby provides an inhibitory signal modulation function. (C) miR-146a
    is activated by NF-κB signaling and negatively feeds back on the pathway by repressing
    upstream activators of NF-κB. In this capacity, miR-146a restrains excessive NF-κB
    activity which can lead to tumorigenesis. (D) Let-7, miR-21, and the miR-143/145
    cluster participate in positive feedback loops which function to stably enforce
    cellular transformation programs upon activation of oncogenes such as NF-κB, Kras,
    and Myc. (E) miR-26 can repress both pro-tumorigenic targets (cyclins D2 and E2)
    and anti-tumorigenic targets (PTEN). These opposing activities endow miR-26 with
    context-dependent positive or negative effects on tumorigenesis.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MAPK3
  - GDE1
  - KRAS
  - MYC
  - MAPK8
  - MAPK14
  - IL6
  - NFKB1
  - MAPK1
  - CCNE2
  - CCND2
  - CDC27
  - LIN28B
  - MAPK11
  - SPRY2
  - PTEN
  - MAPK13
  - TP53
  - CARD10
  - SPRY1
  - MAPK10
  - MAPK12
  - MAPK9
genes:
- word: MAPK/ERK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: miR-16
  symbol: MIR16
  source: hgnc_alias_symbol
  hgnc_symbol: GDE1
  entrez: '51573'
- word: Kras
  symbol: KRAS
  source: hgnc_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: Myc
  symbol: MYC
  source: hgnc_symbol
  hgnc_symbol: MYC
  entrez: '4609'
- word: MAPK/ERK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: MAPK/ERK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: IL-6
  symbol: IL-6
  source: hgnc_alias_symbol
  hgnc_symbol: IL6
  entrez: '3569'
- word: NF-KB
  symbol: NF-kappaB
  source: hgnc_alias_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: MAPK/ERK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: cyclinE2
  symbol: Cyclin-E2
  source: bioentities_symbol
  hgnc_symbol: CCNE2
  entrez: '9134'
- word: cyclinD2
  symbol: Cyclin-D2
  source: bioentities_symbol
  hgnc_symbol: CCND2
  entrez: '894'
- word: CDC27.
  symbol: CDC27
  source: hgnc_symbol
  hgnc_symbol: CDC27
  entrez: '996'
- word: Lin-28b
  symbol: LIN28B
  source: hgnc_symbol
  hgnc_symbol: LIN28B
  entrez: '389421'
- word: MAPK/ERK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: MAPK/ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: Spry2
  symbol: SPRY2
  source: hgnc_symbol
  hgnc_symbol: SPRY2
  entrez: '10253'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: MAPK/ERK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: MAPK/ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: p53
  symbol: p53
  source: hgnc_alias_symbol
  hgnc_symbol: TP53
  entrez: '7157'
- word: CARD10,
  symbol: CARD10
  source: hgnc_symbol
  hgnc_symbol: CARD10
  entrez: '29775'
- word: Spry1
  symbol: SPRY1
  source: hgnc_symbol
  hgnc_symbol: SPRY1
  entrez: '10252'
- word: MAPK/ERK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: MAPK/ERK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: MAPK/ERK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
chemicals: []
diseases: []
figid_alias: PMC3308137__F2
redirect_from: /figures/PMC3308137__F2
figtype: Figure
---
